pemafibrate
Kowa Pharmaceuticals
[]
late breaking trial in #t2dm patients on statins, for high tg (&gt;200), pemafibrate vs placebo. no difference in primary outcome mace a well-done trial, confirms prior negative trials done in mostly non-dm patients
#aha22 
population and clinical scientist, general internist, immigrant, views are mine (she/her)